The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

OBJECTIVE: Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function, while the inhibition of α-cell secretion has received less attention. The aim of this research was to quan...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hare, Kristine J., Vilsbøll, Tina, Asmar, Meena, Deacon, Carolyn F., Knop, Filip K., Holst, Jens J.
Format: Artigo
Sprog:Inglês
Udgivet: American Diabetes Association 2010
Fag:
Pathophysiology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889777/
https://ncbi.nlm.nih.gov/pubmed/20150286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1414
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker